Literature DB >> 21315929

Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases.

Stephen Shuttleworth1, Paul Townsend, Franck Silva, Alexander Cecil, Thomas Hill, Cyrille Tomassi, Helen Rogers, Rebecca Harrison.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21315929     DOI： 10.1016/B978-0-12-381290-2.00003-3

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN： 0079-6468


× No keyword cloud information.
  3 in total

Review 1.  Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors.

Authors:  S J Shuttleworth; F A Silva; A R L Cecil; C D Tomassi; T J Hill; F I Raynaud; P A Clarke; P Workman
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 2.  Proinflammatory Cytokines (IL-1, -6, -8, -15, -17, -18, -23, TNF-α) Single Nucleotide Polymorphisms in Rheumatoid Arthritis-A Literature Review.

Authors:  Olga M Koper-Lenkiewicz; Kinga Sutkowska; Natalia Wawrusiewicz-Kurylonek; Ewa Kowalewska; Joanna Matowicka-Karna
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

Review 3.  Plant-Derived Terpenoids: A Promising Tool in the Fight against Melanoma.

Authors:  Patrycja Kłos; Dariusz Chlubek
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.